Literature DB >> 25636178

Forecasting psychosis by event-related potentials-systematic review and specific meta-analysis.

Mitja Bodatsch1, Anke Brockhaus-Dumke2, Joachim Klosterkötter3, Stephan Ruhrmann3.   

Abstract

BACKGROUND: Prediction and prevention of psychosis have become major research topics. Clinical approaches warrant objective biological parameters to enhance validity in prediction of psychosis onset. In this regard, event-related potentials (ERPs) have been identified as promising tools for improving psychosis prediction.
METHODS: Herein, the focus is on sensory gating, mismatch negativity (MMN) and P300, thereby discussing which parameters allow for a timely and valid detection of future converters to psychosis. In a first step, we systematically reviewed the studies that resulted from a search of the MEDLINE database. In a second step, we performed a meta-analysis of those investigations reporting transitions that statistically compared ERPs in converting versus nonconverting subjects.
RESULTS: Sensory gating, MMN, and P300 have been demonstrated to be impaired in subjects clinically at risk of developing a psychotic disorder. In the meta-analysis, duration MMN achieved the highest effect size measures.
CONCLUSIONS: In summary, MMN studies have produced the most convincing results until now, including independent replication of the predictive validity. However, a synopsis of the literature revealed a relative paucity of ERP studies addressing the psychosis risk state. Considering the high clinical relevance of valid psychosis prediction, future research should question for the most informative paradigms and should allow for meta-analytic evaluation with regard to specificity and sensitivity of the most appropriate parameters.
Copyright © 2015 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Meta-analysis; Mismatch negativity (MMN); P300; Prediction; Prodrome; Psychosis; Sensory gating

Mesh:

Year:  2014        PMID: 25636178     DOI: 10.1016/j.biopsych.2014.09.025

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  32 in total

1.  Developmental timing and critical windows for the treatment of psychiatric disorders.

Authors:  Oscar Marín
Journal:  Nat Med       Date:  2016-10-26       Impact factor: 53.440

Review 2.  Altering the course of schizophrenia: progress and perspectives.

Authors:  Mark J Millan; Annie Andrieux; George Bartzokis; Kristin Cadenhead; Paola Dazzan; Paolo Fusar-Poli; Jürgen Gallinat; Jay Giedd; Dennis R Grayson; Markus Heinrichs; René Kahn; Marie-Odile Krebs; Marion Leboyer; David Lewis; Oscar Marin; Philippe Marin; Andreas Meyer-Lindenberg; Patrick McGorry; Philip McGuire; Michael J Owen; Paul Patterson; Akira Sawa; Michael Spedding; Peter Uhlhaas; Flora Vaccarino; Claes Wahlestedt; Daniel Weinberger
Journal:  Nat Rev Drug Discov       Date:  2016-03-04       Impact factor: 84.694

3.  Reduced Thickness of the Anterior Cingulate Cortex in Individuals With an At-Risk Mental State Who Later Develop Psychosis.

Authors:  Yoichiro Takayanagi; Sue Kulason; Daiki Sasabayashi; Tsutomu Takahashi; Naoyuki Katagiri; Atsushi Sakuma; Chika Obara; Mihoko Nakamura; Mikio Kido; Atsushi Furuichi; Yumiko Nishikawa; Kyo Noguchi; Kazunori Matsumoto; Masafumi Mizuno; J Tilak Ratnanather; Michio Suzuki
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

4.  Rodent Mismatch Negativity/theta Neuro-Oscillatory Response as a Translational Neurophysiological Biomarker for N-Methyl-D-Aspartate Receptor-Based New Treatment Development in Schizophrenia.

Authors:  Migyung Lee; Andrea Balla; Henry Sershen; Pejman Sehatpour; Peter Lakatos; Daniel C Javitt
Journal:  Neuropsychopharmacology       Date:  2017-08-17       Impact factor: 7.853

5.  Antisaccade and prosaccade eye movements in individuals clinically at risk for psychosis: comparison with first-episode schizophrenia and prediction of conversion.

Authors:  Luca Kleineidam; Ingo Frommann; Stephan Ruhrmann; Joachim Klosterkötter; Anke Brockhaus-Dumke; Wolfgang Wölwer; Wolfgang Gaebel; Wolfgang Maier; Michael Wagner; Ulrich Ettinger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-01-11       Impact factor: 5.270

6.  Predicting Remission in Subjects at Clinical High Risk for Psychosis Using Mismatch Negativity.

Authors:  Minah Kim; Tak Hyung Lee; Youngwoo Bryan Yoon; Tae Young Lee; Jun Soo Kwon
Journal:  Schizophr Bull       Date:  2018-04-06       Impact factor: 9.306

7.  Auditory and Visual Oddball Stimulus Processing Deficits in Schizophrenia and the Psychosis Risk Syndrome: Forecasting Psychosis Risk With P300.

Authors:  Holly K Hamilton; Scott W Woods; Brian J Roach; Katiah Llerena; Thomas H McGlashan; Vinod H Srihari; Judith M Ford; Daniel H Mathalon
Journal:  Schizophr Bull       Date:  2019-09-11       Impact factor: 9.306

8.  Impaired Motion Processing in Schizophrenia and the Attenuated Psychosis Syndrome: Etiological and Clinical Implications.

Authors:  Antígona Martínez; Pablo A Gaspar; Steven A Hillyard; Søren K Andersen; Javier Lopez-Calderon; Cheryl M Corcoran; Daniel C Javitt
Journal:  Am J Psychiatry       Date:  2018-10-03       Impact factor: 18.112

9.  Deficits in auditory predictive coding in individuals with the psychosis risk syndrome: Prediction of conversion to psychosis.

Authors:  Susanna L Fryer; Brian J Roach; Holly K Hamilton; Peter Bachman; Aysenil Belger; Ricardo E Carrión; Erica Duncan; Jason Johannesen; Gregory A Light; Margaret Niznikiewicz; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry Seidman; Ming Tsuang; Elaine F Walker; Scott W Woods; Daniel H Mathalon
Journal:  J Abnorm Psychol       Date:  2020-08

10.  Hierarchical Pathways from Sensory Processing to Cognitive, Clinical, and Functional Impairments in Schizophrenia.

Authors:  Daisuke Koshiyama; Michael L Thomas; Makoto Miyakoshi; Yash B Joshi; Juan L Molina; Kumiko Tanaka-Koshiyama; Joyce Sprock; David L Braff; Neal R Swerdlow; Gregory A Light
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.